Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. It also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, the company offers day hospital procedures, such as IVF, endoscopy, gynaecology, urology, dental, ophthalmic, cosmetic surgery, and plastic surgery. As of August 21, 2018, it operated through a network of 126 fertility specialists. The company was founded in 2008 and is headquartered in Greenwich, Australia.
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+61-2-94251722
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$281.43 million
Profitability
Miscellaneous
Employees1,300
Next Earnings DateN/A
OptionableNot Optionable
Virtus Health (ASX:VRT) Frequently Asked Questions
What is Virtus Health's stock symbol?
Virtus Health trades on the ASX under the ticker symbol "VRT."
How often does Virtus Health pay dividends? What is the dividend yield for Virtus Health?
Virtus Health declared a Interim dividend on Wednesday, February 19th. Stockholders of record on Thursday, April 16th will be given a dividend of 0.12 per share on Thursday, April 16th. This represents a dividend yield of 2.59%. The ex-dividend date of this dividend is Wednesday, March 25th. View Virtus Health's Dividend History.
How were Virtus Health's earnings last quarter?
Has Virtus Health been receiving favorable news coverage?
Media headlines about VRT stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Virtus Health earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Virtus Health.
Who are some of Virtus Health's key competitors?
Some companies that are related to Virtus Health include Rhoen Klinikum (RHK), CareTech (CTH), Spire Healthcare Group (SPI), Pacific Smiles Group (PSQ), Georgia Healthcare Group (GHG), Assure (IOM), CENTRIC HEALTH (CHH), Sanara MedTech (SMTI), Totally (TLY), Konekt (KKT), Brain Resource (BRC), Nobilis Health (HLTH), Venn Life Sciences (VENN), Wellness and Beauty (WNB) and Widecells Group (WDC).
What other stocks do shareholders of Virtus Health own?
Who are Virtus Health's key executives?
Virtus Health's management team includes the folowing people:
- Ms. Susan Channon, CEO, MD & Director (Age 62)
- Mr. Glenn Powers, CFO & Company Sec. (Age 59)
- Mr. Steve Zappia, Managing Director of Queensland & Virtus Health Diagnostics (Age 60)
- Ms. Nadia Stankovic, Managing Director of New South Wales
- Ms. Jade Phelan, Managing Director of Victoria
What is Virtus Health's stock price today?
One share of VRT stock can currently be purchased for approximately A$4.77.
How big of a company is Virtus Health?
What is Virtus Health's official website?
How can I contact Virtus Health?
The company can be reached via phone at +61-2-94251722.
MarketBeat Community Rating for Virtus Health (ASX VRT)
MarketBeat's community ratings are surveys of what our community members think about Virtus Health and other stocks. Vote "Outperform" if you believe VRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
